Publications

Journal Articles

  1. Bancroft, S., Heading, C., Guirguis, A., Shah, S., Shah, U., Attar-Zadeh, D. Ethnic disparities in the uptake of pharmacy services The Pharmaceutical Journal 297 7893
  2. Guirguis, A. There is a vulnerable group we must not leave behind in our response to COVID-19: people who are dependent on illicit drugs The Pharmaceutical Journal
  3. Guirguis, A., Moosa, I., Gittins, R., Schifano, F. What about drug checking? Systematic review and netnographic analysis of social media Current Neuropharmacology 18
  4. Arillotta, D., Schifano, F., Napoletano, F., Zangani, C., Gilgar, L., Guirguis, A., Corkery, J., Aguglia, E., Vento, A. Novel Opioids: Systematic Web Crawling Within the e-Psychonauts’ Scenario Frontiers in Neuroscience 14
  5. Ramos, C., Guirguis, A., Smeeton, N., Zaman, H., Felice, A., Bancroft, S., Gittins, R., Hawksworth, G., Corkery, J., Schifano, F. Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances Brain Sciences 10 3 142
  6. Zangani, C., Schifano, F., Napoletano, F., Arillotta, D., Gilgar, L., Guirguis, A., Corkery, J., Gambini, O., Vento, A. The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic Cannabinoids’ Information Available Online Current Neuropharmacology 18
  7. Santos, R., Guirguis, A., Davidson, C. How Pre‐Clinical Studies Have Influenced Novel Psychoactive Substance Legislation in The UK and Europe British Journal of Clinical Pharmacology Swansea
  8. Chiappini, S., Schifano, F., Corkery, J., Guirguis, A. Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database Brain Sciences 10 2 105
  9. Schifano, F., Napoletano, F., Arillotta, D., Zangani, C., Gilgar, L., Guirguis, A., Corkery, J., Vento, A. The clinical challenges of synthetic cathinones British Journal of Clinical Pharmacology
  10. Orsolini, L., Corkery, J., Chiappini, S., Guirguis, A., Guirguis, A., Vento, A., Berardis, D., Papanti, D., Schifano, F. ‘New/Designer Benzodiazepines’: an analysis of the literature and psychonauts’ trip reports Current Neuropharmacology 18
  11. Corkery, J., Schifano, F., Guirguis, A. Commentary on: Attafi IM, Albeishy MY, Oraiby ME, Khardali IA, Shaikhain GA, Fageeh MM. Postmortem Distribution of Cathinone and Cathine in Human Biological Specimens in a Case of Death Associated with Khat Chewing. Arab J Forensic Sci Forensic Med. 2018 Jun 7;1(7). Arab Journal of Forensic Sciences & Forensic Medicine 1 10 1473 1475
  12. Owen, J., Evans, S., Guirguis, A., Kellett, K., Stair, J. Method development for the determination of elements inHypericum perforatumL. (St John's wort) herb and preparations using inductively coupled plasma–optical emission spectroscopy and microwave digestion Journal of Pharmacy and Pharmacology 71 1 38 45
  13. Schifano, F., Chiappini, S., Corkery, J., Guirguis, A. Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems Frontiers in Pharmacology 10
  14. Schifano, F., Chiappini, S., Corkery, J., Guirguis, A. An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions International Journal of Neuropsychopharmacology 22 4 270 277
  15. Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J., Bonaccorso, S., Ricciardi, A., Scherbaum, N., Vento, A., Guirguis, A. New/emerging psychoactive substances and associated psychopathological consequences Psychological Medicine 1 13
  16. Orsolini, L., Chiappini, S., Corkery, J., Guirguis, A., Papanti, D., Schifano, F. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review Expert Review of Neurotherapeutics 19 12 1253 1264
  17. Schifano, F., Napoletano, F., Chiappini, S., Orsolini, L., Guirguis, A., Corkery, J., Bonaccorso, S., Ricciardi, A., Scherbaum, N., Vento, A. New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues Current Addiction Reports
  18. Gittins, R., Guirguis, A., Schifano, F., Maidment, I. Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK Brain Sciences 8 4 58
  19. Schifano, F., Chiappini, S., Corkery, J., Guirguis, A. Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review Brain Sciences 8 4 73
  20. Orsolini, L., Ciccarese, M., Papanti, D., De Berardis, D., Guirguis, A., Corkery, J., Schifano, F. Psychedelic Fauna for Psychonaut Hunters: A Mini-Review Frontiers in Psychiatry 9
  21. Calvo-Castro, J., Guirguis, A., Samaras, E., Zloh, M., Kirton, S., Stair, J. Detection of newly emerging psychoactive substances using Raman spectroscopy and chemometrics RSC Advances 8 56 31924 31933
  22. Guirguis, A., Corkery, J., Stair, J., Kirton, S., Zloh, M., Schifano, F. Intended and unintended use of cathinone mixtures Human Psychopharmacology: Clinical and Experimental 32 3 e2598
  23. Guirguis, A. New psychoactive substances: a public health issue International Journal of Pharmacy Practice 25 5 323 325
  24. Zloh, M., Samaras, E., Calvo-Castro, J., Guirguis, A., Stair, J., Kirton, S. Drowning in diversity? A systematic way of clustering and selecting a representative set of new psychoactive substances RSC Advances 7 84 53181 53191
  25. Orsolini, L., Papanti, G., De Berardis, D., Guirguis, A., Corkery, J., Schifano, F. The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review Frontiers in Psychiatry 8
  26. Guirguis, A., Girotto, S., Berti, B., Stair, J. Identification of new psychoactive substances (NPS) using handheld Raman spectroscopy employing both 785 and 1064 nm laser sources Forensic Science International 273 113 123
  27. Guirguis, A., Girotto, S., Berti, B., Stair, J. Identification of new psychoactive substances using Raman spectroscopy: handheld and computational approaches Research and Advances in Psychiatry 2 3
  28. Guirguis, A. Pharmacy consultation outcomes during a lung cancer awareness campaign
  29. Assi, S., Guirguis, A., Halsey, S., Fergus, S., Stair, J., Guirguis, A. Analysis of ‘legal high’ substances and common adulterants using handheld spectroscopic techniques Analytical Methods 7 2 736 746
  30. Guirguis, A., Corkery, J., Stair, J., Kirton, S., Zloh, M., Goodair, C., Schifano, F., Davidson, C. Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists Drugs and Alcohol Today 15 2 93 99
  31. Guirguis, A. Discovering how to identify new psychoactive substances through PhD research The Pharmaceutical Journal
  32. Guirguis, A. Presence of metals in herbal extracts 536 539

Book Chapters

  1. Schifano, F., Zangani, C., Chiappini, S., Guirguis, A., Bonaccorso, S., Corkery, J. Substance-Use Disorders and Violence (Ed.), Comprehensive Approach to Psychiatry 95 114 Cham Springer International Publishing
  2. Calvo-Castro, J., Zloh, M., Stair, J., Guirguis, A. Raman Spectroscopy for the Analysis of Novel Psychoactive Substances (NPS) (Ed.), Light in Forensic Science Issues and Applications - Comprehensive Series in Photochemical and Photobiological Sciences UK Royal Society of Chemistry
  3. Corkery, J., Guirguis, A., Papanti, D., Orsolini, L., Schifano, F. Synthetic Cathinones—Prevalence and Motivations for Use (Ed.), Synthetic Cathinones: Current Topics in Neurotoxicity, vol 12. Springer, Cham 153 189 Springer, Cham
  4. Guirguis, A., Lawrence, M. New Psychoactive Substances (Ed.), Medicines, Ethics and Practice. The Professional Guide for Pharmacists UK Royal Pharmaceutical Society

Conference Contributions

  1. Guirguis, A., Gittins, R., Calvo-Castro, J., Samaras, E., Zloh, M., Kirton, S., Stair, J. The Development of an Early Warning System for The In-Field Detection of Psychoactive Substances
  2. Guirguis, A., Calvo-Castro, J., Samaras, E., Zloh, M., Kirton, S., Stair, J. Updates on The In-Field Detection of New Psychoactive Substances Research and Advances in Psychiatry 6 1
  3. Guirguis, A. Chemical evaluation of internet products containing new psychoactive substances to investigate supply/ distribution chains
  4. Guirguis, A. Community Pharmacist interventions and improved COPD management npj Primary Care Respiratory Medicine

Other Research Outputs

  1. Guirguis, A. The next wave of Psychoactive Substances London - UK RPS Science and Research Summit
  2. Calvo-Castro, J., Guirguis, A., Guarino, V., Samaras, E., Zloh, M., Simionato, C., Kirton, S., Stair, J. GC-MS data for mexedrone
  3. Calvo-Castro, J., Guirguis, A., Guarino, V., Samaras, E., Zloh, M., Simionato, C., Kirton, S., Stair, J. GC-MS and NMR data for (1-Butyl-1H-indol-3-yl)(1-naphthyl)methanone UK
  4. Calvo-Castro, J., Guirguis, A., Guarino, V., Samaras, E., Zloh, M., Simionato, C., Kirton, S., Stair, J. GC-MS and NMR data for 5-(2-aminopropyl)benzofuran
  5. Calvo-Castro, J., Guirguis, A., Guarino, V., Samaras, E., Zloh, M., Simionato, C., Kirton, S., Stair, J. GC-MS and NMR data for 6-(2-aminopropyl)benzofuran
  6. Calvo-Castro, J., Guirguis, A., Guarino, V., Samaras, E., Zloh, M., Simionato, C., Kirton, S., Stair, J. GC-MS data for 5-MeO-DALT (5-Methoxy-N,N-diallytryptamine)
  7. Guirguis, A. Substance use and misuse
  8. Guirguis, A. Written evidence to the psychoactive substances inquiry